Type and etiology of CNS infection Type of

  • Slides: 32
Download presentation

Type and etiology of CNS infection Type of CNS Acute (“ 5 days”) infection

Type and etiology of CNS infection Type of CNS Acute (“ 5 days”) infection Meningitis ** Bacteria (S. pneumoniae) ** Virus (Enterovirus, HSV 2) Encephalitis Viruses (HSV-1) Brain abscess Subacute~chronic (“> 5 days”) ** Mycobacterium tuberculosis Cryptococcus neoformans Bacteria (streptococci + anaerobes) Harrison’s Principles of Internal Medicine, 18 e. chapter 381

Meningeal irritation sign

Meningeal irritation sign

Management of bacterial meningitis “급성 발열과 두통 ” 요추천자 바로 못 할 때는 “혈액

Management of bacterial meningitis “급성 발열과 두통 ” 요추천자 바로 못 할 때는 “혈액 배양” 하고 바로 항균제 치료 시작 Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267 -84

CSF tapping WBC 750/m. L (poly 90%) protein 550 mg/L, glucose 20 mg/L

CSF tapping WBC 750/m. L (poly 90%) protein 550 mg/L, glucose 20 mg/L

CSF finding by type of meningitis Pressure (mm. H 2 O) Acute meningitis Subacute~chronic

CSF finding by type of meningitis Pressure (mm. H 2 O) Acute meningitis Subacute~chronic meningitis Normal Bacteria Virus Tuberculosis Cryptococcus 90 -180 N- WBC/mm 3 0 -5 > 1, 000 5 -1, 000 25 -500 % PMNs 0 -15 90 < 50* 10 -1, 000 (평균 50) < 50 Protein (mg/d. L) 20 -50 100 -500 100 -200 20 -500 Glucose (mg/d. L) 40 -70 < 40 N** (< 40 in 3/4) (< 30) 0. 6 < 0. 4 0. 6 CSF/serum glucose Gram stain, culture N- (50 -100) PCR * Lymphocyte가 우세하지만, 초기에는 PMN 80%까지 가능 ** Mumps, HSV, CMV 중 1/4에서 감소 AFB stain TB-PCR Mycobacteri al culture Indian ink Cryptococcal latex agglutination test

S. pneumoniae meningitis의 항균제 CSF, blood: S. pneumoniea 동정 PCN MIC 0. 03 (S),

S. pneumoniae meningitis의 항균제 CSF, blood: S. pneumoniea 동정 PCN MIC 0. 03 (S), Ceftriaxone MIC 0. 5 (S) Penicillin MIC Standard therapy 0. 06 g/m. L (S) Penicillin 0. 06 -1. 0 g/m. L (I) Cefotaxime or ceftriaxone ≥ 2. 0 g/m. L (R) Vancomycin plus (Cefotaxime or ceftriaxone) Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267 -84

경험적 항균제 선택의 기준이 되는 것은? 1. CSF profiles compatible bacterial meningitis 2. CSF

경험적 항균제 선택의 기준이 되는 것은? 1. CSF profiles compatible bacterial meningitis 2. CSF Gram stain & culture / blood culture 3. latex agglutination test 4. Age and predisposing conditions

CSF gram stain Gram(-) diplococci: S. pneumoniae http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

CSF gram stain Gram(-) diplococci: S. pneumoniae http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

CSF gram stain Gram(-) diplococci: N. meningitis http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

CSF gram stain Gram(-) diplococci: N. meningitis http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

CSF gram stain Gram(-) rods: H. influenzae http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

CSF gram stain Gram(-) rods: H. influenzae http: //www. cdc. gov/meningitis/lab-manual/chpt 06 -culture-id. html

나이별 주요 원인 균 Ceftriaxone + vancomycin Ampicillin Schuchat A, et al. N Engl

나이별 주요 원인 균 Ceftriaxone + vancomycin Ampicillin Schuchat A, et al. N Engl J Med 1997; 337: 970 -6.

Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267 -84

Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267 -84

얼마나 오래 항균제를 투여하나? Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267

얼마나 오래 항균제를 투여하나? Tunkel AR, et al. Clin Infect Dis 2004; 39: 1267 -84

Outcomes Swartz MN. N Engl J Med 2004; 351: 1826 -8

Outcomes Swartz MN. N Engl J Med 2004; 351: 1826 -8

Purpura fulminans

Purpura fulminans

Meningococcal meningitis v 13 serogroups; A/B/C/Y/W 135 - nearly all diseases v A (C);

Meningococcal meningitis v 13 serogroups; A/B/C/Y/W 135 - nearly all diseases v A (C); third-world countries v B & C; industrialized (90% in US) v Endemic rates are low but epidemics ! v meningitis, septicemia, septic shock with MOF v Mortality is still > 10% (septicemia 40%) v No other infection so quickly kills ! 사망자 1/2은 첫 증상 후 24시간 내 사망 사망자 1/3은 입원 후 6시간 내 사망 생존자의 11~19%는 후유증이 남음

왜 신병에서 발생하나? v Age of high risk; < 4 & 15 ~ 24

왜 신병에서 발생하나? v Age of high risk; < 4 & 15 ~ 24 years old v Diverse geographic areas & strains v Crowded living conditions v In US Army, vaccination since 1971 v Dormitory of US College in 1998 ~ 99 2. 2 / 100, 000 / yr vs. 1. 4 of same age group

미군에서의 예방접종효과 C C/A/Y/W Maiden MC. Philos Trans R Soc Lond B Biol Sci

미군에서의 예방접종효과 C C/A/Y/W Maiden MC. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120147

v Basal meninges v CSF AFB (-) v CSF culture: 6 weeks later, M.

v Basal meninges v CSF AFB (-) v CSF culture: 6 weeks later, M. tuberculosis contrast-enhanced T 1 -weighted MRI

결핵성 수막염의 병인 1. inhalation 3. lymphatics thoracic duct 2. multiply 4. General circulation

결핵성 수막염의 병인 1. inhalation 3. lymphatics thoracic duct 2. multiply 4. General circulation 5. metastatic foci

결핵성 수막염의 병인 v primary infection Hematogenous spread Rupture of subependymal tubercles spread to

결핵성 수막염의 병인 v primary infection Hematogenous spread Rupture of subependymal tubercles spread to subarachnoid space basilar portion of brain tuberculous meningitis

결핵성 수막염의 임상적 발현 v Subacute to chronic course v Fever, headache, night sweat,

결핵성 수막염의 임상적 발현 v Subacute to chronic course v Fever, headache, night sweat, weight loss, malaise, lethargy v Infarct, SOL, hydrocephalus headache, vomiting, confusion, seizure v Cranial nerve involvement IV (trochlear) > II, III, VIII

결핵성 수막염의 진찰소견 v Chest X-ray; pulmonary tuberculosis ? v Stiff neck, cranial nerve

결핵성 수막염의 진찰소견 v Chest X-ray; pulmonary tuberculosis ? v Stiff neck, cranial nerve defects v Fundoscopic examination: choroidal tubercle

결핵성 수막염의 진단 v 확진이 매우 어렵다 - 의심해야 진단할 수 있다. v CSF

결핵성 수막염의 진단 v 확진이 매우 어렵다 - 의심해야 진단할 수 있다. v CSF 소견 fungal, partially treated bacterial meningitis와 비슷 gross; clear or slightly opaque overnight stand; small wisp-like pellicle WBC; 100 -500/ L (PMN to MN) protein; elevated glucose; < 45 -50 mg/dl (< 1/2 serum level) v CSF AFB smear (<20%) v CSF culture (50 -80%) v PCR sensitivity (~50%)

결핵성 수막염의 치료 v Prompt Anti-TB medication : 12 months cf. osteoarticular TB: 6~9

결핵성 수막염의 치료 v Prompt Anti-TB medication : 12 months cf. osteoarticular TB: 6~9 months v Steroid adjunctive therapy